Jason Hoffman, PharmD, RPh

Most Recent Articles by Jason Hoffman, PharmD, RPh

No Intervention for Small Thyroid Cancers May Cause Anxiety

No Intervention for Small Thyroid Cancers May Cause Anxiety

By

Deciding not to intervene for small, incidentally identified thyroid cancer may cause patients to experience anxiety and feelings of isolation.

Regorafenib Improves Quality-adjusted Survival in Sarcoma

Regorafenib Improves Quality-adjusted Survival in Sarcoma

By

In patients with soft tissue sarcoma pretreated with doxorubicin, treatment with regorafenib significantly reduced the risk of progression symptoms or toxicity.

Screening Increases Early Palliative Care, Reduces Aggressive EOL Measures

Screening Increases Early Palliative Care, Reduces Aggressive EOL Measures

By

Universal screening of women with gynecologic malignancies for early palliative care decreased the use of aggressive measures at the end of life.

High Rates of Persistent Opioid Use 6 Months After RT for Cervical Cancer

High Rates of Persistent Opioid Use 6 Months After RT for Cervical Cancer

By

Nearly 3 in 10 cervical cancer survivors were still using opioids at 6 months after completing radiotherapy.

HPV Vaccination Discussions Need to Focus on Education, Awareness

HPV Vaccination Discussions Need to Focus on Education, Awareness

By

The top reasons for not initiating HPV vaccination are necessity, safety, and knowledge, rather than a lack of discussions on sexuality.

More Articles by Jason Hoffman, PharmD, RPh

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs